These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 16212902)
41. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia]. Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557 [TBL] [Abstract][Full Text] [Related]
42. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis. Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016 [TBL] [Abstract][Full Text] [Related]
43. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Huerta-Yepez S; Vega M; Garban H; Bonavida B Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892 [TBL] [Abstract][Full Text] [Related]
44. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells. Liu WH; Cheng YC; Chang LS J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563 [TBL] [Abstract][Full Text] [Related]
45. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway. Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335 [TBL] [Abstract][Full Text] [Related]
46. Fas-mediated apoptosis with normal expression of bcl-2 and p53 in lymphocytes from aplastic anaemia. Callera F; Garcia AB; Falcão RP Br J Haematol; 1998 Mar; 100(4):698-703. PubMed ID: 9580207 [TBL] [Abstract][Full Text] [Related]
47. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells. Xu T; Sun BC; Li Q; Hao XS World J Gastroenterol; 2005 Jul; 11(25):3915-9. PubMed ID: 15991293 [TBL] [Abstract][Full Text] [Related]
48. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL. Rich RF; Cook WJ; Green WR Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984 [TBL] [Abstract][Full Text] [Related]
49. The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells. Kirkin V; Cahuzac N; Guardiola-Serrano F; Huault S; Lückerath K; Friedmann E; Novac N; Wels WS; Martoglio B; Hueber AO; Zörnig M Cell Death Differ; 2007 Sep; 14(9):1678-87. PubMed ID: 17557115 [TBL] [Abstract][Full Text] [Related]
50. A new role of diacylglycerol kinase alpha on the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytes. Alonso R; Mazzeo C; Mérida I; Izquierdo M Biochimie; 2007 Feb; 89(2):213-21. PubMed ID: 16989932 [TBL] [Abstract][Full Text] [Related]
51. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway. Liu WH; Chang LS Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122 [TBL] [Abstract][Full Text] [Related]
52. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure. Mita A; Hashikura Y; Tagawa Y; Nakayama J; Kawakubo M; Miyagawa S Am J Gastroenterol; 2005 Nov; 100(11):2551-9. PubMed ID: 16279913 [TBL] [Abstract][Full Text] [Related]
53. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858 [TBL] [Abstract][Full Text] [Related]
54. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. Kiener PA; Davis PM; Rankin BM; Klebanoff SJ; Ledbetter JA; Starling GC; Liles WC J Immunol; 1997 Aug; 159(4):1594-8. PubMed ID: 9257817 [TBL] [Abstract][Full Text] [Related]
55. Effect of protein kinase C on proliferation and apoptosis of T lymphocytes in idiopathic thrombocytopenic purpura children. Wu C; Liu F; Zhou X; Cheng Z; Yang X; Xiao H; Chen Q; Cai K Cell Mol Immunol; 2005 Jun; 2(3):197-203. PubMed ID: 16212887 [TBL] [Abstract][Full Text] [Related]
56. Impaired apoptosis and immune senescence - cause or effect? Hsu HC; Scott DK; Mountz JD Immunol Rev; 2005 Jun; 205():130-46. PubMed ID: 15882350 [TBL] [Abstract][Full Text] [Related]
57. Lymphocytes with T-cell-like properties express the Fas ligand in the Japanese flounder Paralichthys olivaceus. Kurata O; Iwasaki T; Matsuyama T; Nakayasu C; Wada S; Hatai K Fish Shellfish Immunol; 2011 Feb; 30(2):509-14. PubMed ID: 21134463 [TBL] [Abstract][Full Text] [Related]
58. Fas/FasL in the immune pathogenesis of severe aplastic anemia. Liu CY; Fu R; Wang HQ; Li LJ; Liu H; Guan J; Wang T; Qi WW; Ruan EB; Qu W; Wang GJ; Liu H; Wu YH; Song J; Xing LM; Shao ZH Genet Mol Res; 2014 May; 13(2):4083-8. PubMed ID: 24938700 [TBL] [Abstract][Full Text] [Related]
59. Presence of membrane and soluble forms of Fas ligand and of matrilysin (MMP-7) activity in normal and abnormal human semen. Riccioli A; Dal Secco V; De Cesaris P; Starace D; Gandini L; Lenzi A; Dondero F; Padula F; Filippini A; Ziparo E Hum Reprod; 2005 Oct; 20(10):2814-20. PubMed ID: 15979995 [TBL] [Abstract][Full Text] [Related]
60. Expression of membrane-bound IL-15 by bone marrow fibroblast-like stromal cells in aplastic anemia. Wenxin L; Jinxiang F; Yong W; Wenxiang L; Wenbiao S; Xueguang Z Int Immunol; 2005 Apr; 17(4):429-37. PubMed ID: 15749732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]